plerixafor has been researched along with Innate Inflammatory Response in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 16 (72.73) | 24.3611 |
| 2020's | 6 (27.27) | 2.80 |
| Authors | Studies |
|---|---|
| Bai, R; Feng, A; Liang, Z; Oum, Y; Salgado, E; Shim, H; Sun, J; Xie, Y; Yoon, Y | 1 |
| Liang, Z; Mooring, SR; Shim, H; Virani, S; Yoon, Y | 1 |
| Bai, R; Feng, A; Jie, X; Liang, Z; Oum, Y; Salgado, E; Shim, H; Sun, B; Sun, J; Wu, R; Xie, Y; Yoon, Y; Yu, W | 1 |
| Allgöwer, A; Braumüller, S; Brown, A; Cancelas, JA; Geiger, H; Huber-Lang, M; Möhrle, B; Palmer, A; Sakk, V; Vogel, M | 1 |
| Chen, S; Liu, E; Tang, W; Tang, Z; Yu, G | 1 |
| Barbiro, B; Ezra, A; Gavriel, Y; Rabinovich-Nikitin, I; Solomon, B | 1 |
| Aknin, ML; Bachelerie, F; Balabanian, K; Bertrand, Y; Calmette, J; Donadieu, J; Evrard, M; Gallego, C; Lefrançois, M; Marin-Esteban, V; Mercier-Nomé, F; Ng, LG; Pionnier, N; Roriz, M; Schlecht-Louf, G; Suarez, F; Vétillard, M | 1 |
| Lai, WY; Mueller, A | 1 |
| Fan, B; Fu, Y; Gao, F; Jiang, T; Li, T; Li, X; Li, Y; Liu, P; Qin, X; Sun, H; Wang, Q; Wang, Y; Zheng, Q; Zhou, X | 1 |
| Fan, YH; Huang, SS; Li, F; Wei, L; Xue, ZY; Yuan, Y; Zhu, X | 1 |
| De Filippo, K; Rankin, SM | 1 |
| Mueller, AM; Sadiq, SA; Yoon, BH | 1 |
| Ganesan, S; Gao, JL; Li, Z; Liu, Q; McDermott, DH; Murphy, PM; Wan, W | 1 |
| Drummond, S; Hehre, D; Huang, J; Ramachandran, S; Suguihara, C; Torres, E; Young, KC | 1 |
| Jiang, TH; Mao, AW; Peng, J; Sun, XJ | 1 |
| Bao, M; Guan, Y; Guo, R; Li, X; Wang, Y; Wu, A; Xie, F; Yue, Y; Zhang, C | 1 |
| Guo, Y; Hu, Z; Liao, W; Mou, J; Pei, G; Sun, J; Wang, M; Wang, P; Wang, X; Xu, G; Yang, J; Yao, W; Yao, Y; Zeng, R; Zhao, Z; Zhu, F | 1 |
| Guo, YY; Li, YJ; Liu, SB; Sun, T; Wang, M; Wu, YM; Yang, L; Yang, Q; Zhang, K; Zhao, MG | 1 |
| Lupp, A; Seemann, S | 1 |
| Li, XQ; Ma, H; Sun, XJ; Tan, WF; Zhang, ZL | 1 |
| Lazennec, G; Richmond, A | 1 |
| Huang, J; Li, Y; Tang, G; Tang, Y; Wang, Y; Yang, GY | 1 |
3 review(s) available for plerixafor and Innate Inflammatory Response
| Article | Year |
|---|---|
Latest update on chemokine receptors as therapeutic targets.
Topics: Animals; Antibodies, Monoclonal, Humanized; Benzylamines; Chemokines; Cyclams; Humans; Inflammation; Maraviroc; Molecular Targeted Therapy; Neoplasms; Protein Binding; Receptors, Chemokine; Signal Transduction | 2021 |
CXCR4, the master regulator of neutrophil trafficking in homeostasis and disease.
Topics: Animals; Benzylamines; Bone Marrow; Cell Survival; Chemokine CXCL12; Cyclams; Hematologic Agents; Heterocyclic Compounds; HMGB1 Protein; Homeostasis; Humans; Imidazoles; Immunologic Deficiency Syndromes; Inflammation; Mice; Mutation; Neutrophils; Peptide Fragments; Primary Immunodeficiency Diseases; Receptors, CXCR4; Serum Albumin; Spleen; Warts | 2018 |
Chemokines and chemokine receptors: new insights into cancer-related inflammation.
Topics: Benzylamines; Chemokines; Clinical Trials as Topic; Cyclams; Heterocyclic Compounds; Humans; Inflammation; Models, Biological; Neoplasms; Receptors, Chemokine; Receptors, CXCR4 | 2010 |
19 other study(ies) available for plerixafor and Innate Inflammatory Response
| Article | Year |
|---|---|
Anti-inflammatory hybrids of secondary amines and amide-sulfamide derivatives.
Topics: Amides; Amines; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chemokine CXCL12; Dose-Response Relationship, Drug; Ear; Edema; Humans; Inflammation; Mice; Mice, Nude; Molecular Structure; Receptors, CXCR4; Structure-Activity Relationship | 2018 |
Synthesis and evaluation of 2,5-diamino and 2,5-dianilinomethyl pyridine analogues as potential CXCR4 antagonists.
Topics: Animals; Carrageenan; Dose-Response Relationship, Drug; Drug Design; Edema; Humans; Inflammation; Mice; Molecular Structure; Pyridines; Receptors, CXCR4; Structure-Activity Relationship | 2019 |
Development of CXCR4 modulators based on the lead compound RB-108.
Topics: Amides; Animals; Anti-Inflammatory Agents, Non-Steroidal; Carrageenan; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Humans; Inflammation; Mice; Mice, Inbred C57BL; Molecular Structure; Rats; Rats, Sprague-Dawley; Receptors, CXCR4; Structure-Activity Relationship | 2019 |
A Limited Role for AMD3100 Induced Stem Cell Mobilization for Modulation of Thoracic Trauma Outcome.
Topics: Animals; Benzylamines; Cyclams; Hematopoietic Stem Cell Mobilization; Inflammation; Mice; Thoracic Injuries; Wounds, Nonpenetrating | 2022 |
CXCL12/CXCR4 Axis is Involved in the Recruitment of NK Cells by HMGB1 Contributing to Persistent Airway Inflammation and AHR During the Late Stage of RSV Infection.
Topics: Animals; Chemokine CXCL12; Inflammation; Killer Cells, Natural; Mice; Mice, Nude; Respiratory Syncytial Virus Infections; Respiratory Syncytial Virus, Human | 2023 |
Subcutaneous Administration of AMD3100 into Mice Models of Alzheimer's Disease Ameliorated Cognitive Impairment, Reduced Neuroinflammation, and Improved Pathophysiological Markers.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Anti-HIV Agents; Benzylamines; Biomarkers; Cognitive Dysfunction; Cyclams; Disease Models, Animal; Inflammation; Inflammation Mediators; Injections, Intraventricular; Injections, Subcutaneous; Male; Maze Learning; Mice; Mice, Inbred C57BL; Mice, Transgenic; Peptide Fragments | 2020 |
CXCR4 signaling controls dendritic cell location and activation at steady state and in inflammation.
Topics: Alphapapillomavirus; Animals; Benzylamines; Cell Count; Cell Differentiation; Chemokine CXCL12; Chemotaxis; Cyclams; Dendritic Cells; Epidermis; Female; Gene Knock-In Techniques; Genes, Viral; Humans; Inflammation; Langerhans Cells; Lymphoid Tissue; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Mice, Transgenic; Organ Specificity; Parabiosis; Primary Immunodeficiency Diseases; Receptors, CXCR4; Recombinant Proteins; Warts | 2021 |
CXCL12/CXCR4 axis as a key mediator in atrial fibrillation via bioinformatics analysis and functional identification.
Topics: Animals; Atrial Fibrillation; Benzylamines; Case-Control Studies; Chemokine CXCL12; Computational Biology; Cyclams; Databases, Genetic; Disease Models, Animal; Electrocardiography; Fibrosis; Gene Expression Profiling; Gene Ontology; Gene Regulatory Networks; Heart Atria; Humans; Inflammation; Macrophages; Mice, Inbred C57BL; Phosphorylation; Receptors, CXCR4; Signal Transduction; T-Lymphocytes; Vascular Remodeling | 2021 |
Upregulation of CXCR4 through promoter demethylation contributes to inflammatory hyperalgesia in rats.
Topics: Animals; Benzylamines; Chromatin Immunoprecipitation; Cyclams; Demethylation; Freund's Adjuvant; Heterocyclic Compounds; Hyperalgesia; Inflammation; Male; Pain Measurement; Pain Threshold; Rats; Rats, Sprague-Dawley; Receptors, CXCR4; RNA, Messenger; Up-Regulation | 2018 |
Inhibition of hyaluronan synthesis protects against central nervous system (CNS) autoimmunity and increases CXCL12 expression in the inflamed CNS.
Topics: Adoptive Transfer; Animals; Anti-HIV Agents; Benzylamines; Central Nervous System; Chemokine CXCL12; Cyclams; Encephalomyelitis, Autoimmune, Experimental; Female; Gene Expression Regulation; Heterocyclic Compounds; Hyaluronic Acid; Inflammation; Mice; Rats; T-Lymphocytes, Regulatory; Th1 Cells | 2014 |
CXCR4 antagonist AMD3100 redistributes leukocytes from primary immune organs to secondary immune organs, lung, and blood in mice.
Topics: Animals; Benzylamines; Bone Marrow; Cell Movement; Cyclams; Female; Heterocyclic Compounds; Immunophenotyping; Inflammation; Leukocyte Count; Leukocytes; Lung; Lymph Nodes; Mice; Phenotype; Receptors, CXCR4; Spleen; T-Lymphocyte Subsets; Thymus Gland | 2015 |
CXCR4 blockade attenuates hyperoxia-induced lung injury in neonatal rats.
Topics: Animals; Animals, Newborn; Benzylamines; Bronchopulmonary Dysplasia; Cyclams; Disease Models, Animal; Heterocyclic Compounds; Hyperoxia; Hypertension, Pulmonary; Inflammation; Pulmonary Alveoli; Rats; Rats, Sprague-Dawley; Receptors, CXCR4 | 2015 |
Application of chemokine receptor antagonist with stents reduces local inflammation and suppresses cancer growth.
Topics: Animals; Benzylamines; Cell Line, Tumor; Cell Proliferation; Chemokine CXCL12; Cyclams; Heterocyclic Compounds; Humans; Inflammation; Mice; Neoplasms, Experimental; Pancreatic Neoplasms; Receptors, CXCR4; Signal Transduction; Stents; Xenograft Model Antitumor Assays | 2015 |
Plerixafor may treat intractable post-herpetic neuralgia.
Topics: Benzylamines; Bone Marrow Cells; Cell Movement; Cyclams; Ganglion Cysts; Herpes Zoster; Heterocyclic Compounds; Humans; Inflammation; Lymphoma, Non-Hodgkin; Models, Theoretical; Multiple Myeloma; Neuralgia; Neuralgia, Postherpetic; Neurons; Spinal Cord; Stem Cell Transplantation; Stem Cells; United States | 2015 |
Continuous AMD3100 Treatment Worsens Renal Fibrosis through Regulation of Bone Marrow Derived Pro-Angiogenic Cells Homing and T-Cell-Related Inflammation.
Topics: Animals; Benzylamines; Bone Marrow; CD3 Complex; Cell Proliferation; Chemotaxis; Collagen Type IV; Cyclams; Cytokines; Fibrosis; Heterocyclic Compounds; Hypoxia; Inflammation; Kidney; Kidney Tubules; Male; Mice, Inbred C57BL; Neovascularization, Physiologic; Receptor, Platelet-Derived Growth Factor beta; T-Lymphocytes; Ureteral Obstruction | 2016 |
Systemic inflammation induces anxiety disorder through CXCL12/CXCR4 pathway.
Topics: Animals; Anxiety; Basolateral Nuclear Complex; Behavior, Animal; Benzylamines; Chemokine CXCL12; Cyclams; Heterocyclic Compounds; Inflammation; Lipopolysaccharides; Male; Mice; Mice, Inbred C57BL; Receptors, CXCR4; RNA, Small Interfering; Synaptic Transmission | 2016 |
Administration of AMD3100 in endotoxemia is associated with pro-inflammatory, pro-oxidative, and pro-apoptotic effects in vivo.
Topics: Animals; Anti-HIV Agents; Apoptosis; Benzylamines; Chemokine CXCL12; Cyclams; Endotoxemia; Heterocyclic Compounds; Inflammation; Injections, Intraperitoneal; Lipopolysaccharides; Liver; Male; Mice, Inbred C57BL; Oxidation-Reduction; Receptors, CXCR4; Spleen | 2016 |
Down-Regulation of CXCL12/CXCR4 Expression Alleviates Ischemia-Reperfusion-Induced Inflammatory Pain via Inhibiting Glial TLR4 Activation in the Spinal Cord.
Topics: Animals; Astrocytes; Behavior, Animal; Benzylamines; Chemokine CXCL12; Cyclams; Down-Regulation; Heterocyclic Compounds; Hyperalgesia; Inflammation; Microglia; Pain; Rats; Rats, Sprague-Dawley; Receptors, CXCR4; Reperfusion Injury; Spinal Cord; Sulfonamides; Toll-Like Receptor 4 | 2016 |
CXCR4 antagonist AMD3100 protects blood-brain barrier integrity and reduces inflammatory response after focal ischemia in mice.
Topics: Animals; Benzylamines; Blood-Brain Barrier; Brain Ischemia; Cyclams; Heterocyclic Compounds; Inflammation; Male; Mice; Neuroprotective Agents; Neutrophil Infiltration; Receptors, CXCR4 | 2013 |